Security Snapshot

Alzamend Neuro, Inc. - Common Stock, par value $0.0001 per share (ALZN) Institutional Ownership

CUSIP: 02262M605

13F Institutional Holders and Ownership History from Q2 2025 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

12

Shares (Excl. Options)

2.72MFull value: 2,719,501 · shares · 30 Jun 2026

Price

$1.20

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock, par value $0.0001 per share
Symbol
ALZN on Nasdaq
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
2,719,501
Latest holder snapshot 5 signals
Total 13F value
$3,263,398
Portfolio coverage rank
0%
Share change
+2,037,285
Value change
+$2,449,395
Number of holders
12
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
3,793,386
SEC-reported price per share
$1.35
Insider filing price
$1.35
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • ALZN - Alzamend Neuro, Inc. - Common Stock, par value $0.0001 per share is tracked under CUSIP 02262M605.
  • 12 institutions reported positions in Q2 2026.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 13 to 12 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $723.15KFull value: $723,147 · USD · 31 Mar 2026
    to
    $3.26MFull value: $3,263,398 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 12 institutions filings for Q2 2026.

Open SEC evidence

Security key

02262M605

13F reference period

Q2 2026

13F holders

12

13D/G owners

1

CIK / CUSIP context first

Open Q2 2026 holders ALZN full holder history Alzamend Neuro, Inc. SEC filings Alzamend Neuro, Inc. company facts Alzamend Neuro, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
ALZN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AULT MILTON C III 4.4% -45% $410,596 -$342,954 166,909 -46% MILTON C. AULT, III 03 Oct 2025
As of 30 Jun 2026, 12 institutional investors reported holding
2.72MFull value: 2,719,501 · shares · 30 Jun 2026
shares of Alzamend Neuro, Inc. - Common Stock, par value $0.0001 per share (ALZN). This represents 72% of the company’s total
3.79MFull value: 3,793,386 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 15 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
72%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Kingsbury Capital Investment Advisors LLC 35% 1,329,100 +135% 1.3% $1,594,920
KMT WEALTH MANAGEMENT, LLC 35% 1,329,100 1.3% $1,594,920
GEODE CAPITAL MANAGEMENT, LLC 0.7% 26,371 -42% 0% $31,644
VANGUARD FIDUCIARY TRUST CO 0.55% 21,020 0% 0% $25,224
VANGUARD CAPITAL MANAGEMENT LLC 0.2% 7,556 +72% 0% $9,067
Tower Research Capital LLC (TRC) 0.09% 3,517 -43% 0% $4,220
UBS Group AG 0.06% 2,352 -48% 0% $2,822
BlackRock, Inc. 0.01% 437 0% 0% $524
IFG Advisory, LLC 0% 22 0% $26
SBI Securities Co., Ltd. 0% 22 0% 0% $26
Caitong International Asset Management Co., Ltd 0% 3 -25% 0% $4
HARBOR INVESTMENT ADVISORY, LLC 0% 1 0% 0% $1
MORGAN STANLEY 0% 0 -100% $0
Clearstead Advisors, LLC 0% 0 -100% $0
CITIGROUP INC 0% 0 -100% $0

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
6
Headline period
Q2 2026
Rows shown
1-6 of 6
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 1,119,955 $1,937,522 -$361,861 $1.73 3
2026 Q2 2,719,501 $3,263,398 +$2,449,395 $1.20 12
2026 Q1 682,216 $723,147 -$249,577 $1.06 13
2025 Q4 245,648 $447,177 +$178,507 $1.82 13
2025 Q3 147,622 $351,338 +$346,139 $2.38 11
2025 Q2 2,184 $6,355 +$6,355 $2.91 7
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .